We’ve all had those days when our stomachs feel a little off, maybe it’s a bit of bloating, or that all-too-familiar feeling ...

While older millennials currently have the the highest rates, researchers believe cases may continue to rise among younger generations.

Now, nivolumab -- in combination with chemotherapy -- is indicated for the first-line treatment of adults with unresectable ...

Atezolizumab may improve upon perioperative treatment with trastuzumab and chemotherapy in HER2+, locally advanced, resectable gastric or GEJ cancer, researchers say.

Gastric cancer, which is the fifth most frequent cancer globally and the third most frequent cause of cancer-related deaths, can be managed relatively well with existing therapies. Advanced gastric ...

Colorectal cancer offered the earliest window into the trend of increased cancer incidence among those younger than age 50.

When it comes to the use of PD-1 inhibitors in stomach cancer, the FDA has put its money where its mouth is. | After ...

A low prognostic nutritional index is associated with an increased risk for 90-day mortality and adverse postoperative ...

T-cell therapy has shown remarkable clinical efficacy in haematological malignancies, currently representing a well ...

Certain GI disorders share microbial biomarkers, with researchers predicting this could lead to new diagnostic tools for ...

Satri-cel, a CLDN18.2-targeted CAR T-cell therapy, nearly doubles progression-free survival in patients with previously ...

For the first time, a medicine aimed directly at the HER2 protein improved overall survival after gastric cancer progressed ...